These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22652186)

  • 21. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A; Pawar G
    W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
    Shariat-Madar B; Chun RH; Sulman CG; Conley SF
    Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
    Sridharan K; Sivaramakrishnan G
    J Clin Neurosci; 2018 May; 51():12-17. PubMed ID: 29475576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.
    Molloy L
    Curr Opin Neurol; 2007 Aug; 20(4):493-8. PubMed ID: 17620887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The current approach to hyper-sialorrhea].
    Defossez W
    Rev Belge Med Dent (1984); 2006; 61(3):173-9. PubMed ID: 17408138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of botulinum toxin A for treatment of drooling.
    Lipp A; Trottenberg T; Schink T; Kupsch A; Arnold G
    Neurology; 2003 Nov; 61(9):1279-81. PubMed ID: 14610139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
    Deshpande AV; Sampang R; Smith GH
    ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type A for neuropathic itch.
    Wallengren J; Bartosik J
    Br J Dermatol; 2010 Aug; 163(2):424-6. PubMed ID: 20346021
    [No Abstract]   [Full Text] [Related]  

  • 33. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A
    Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036
    [No Abstract]   [Full Text] [Related]  

  • 35. Botulinum toxin versus submandibular duct relocation for severe drooling.
    Scheffer AR; Erasmus C; VAN Hulst K; VAN Limbeek J; Rotteveel JJ; Jongerius PH; van den Hoogen FJ
    Dev Med Child Neurol; 2010 Nov; 52(11):1038-42. PubMed ID: 20561006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of drooling: 10 years after the Consortium on Drooling 1990.
    Berweck S; Schwerin A; Heinen F
    Dev Med Child Neurol; 2003 Dec; 45(12):845; author reply 845-6. PubMed ID: 14667080
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: A randomized controlled trial.
    Dev Med Child Neurol; 2023 Mar; 65(3):e27. PubMed ID: 36002945
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drooling therapy in children with neurological disorders].
    Táboas-Pereira MA; Paredes-Mercado C; Alonso-Curcó X; Badosa-Pagès J; Muchart J; Póo P
    Rev Neurol; 2015 Jul; 61(2):66-70. PubMed ID: 26156441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.